Dartmouth-Hitchcock logo
Back
 
An Infectious Disease Perspective: Opioid Use Disorder and Commonly Co-Occurring Conditions in Pregnant Women

This presentation discusses the epidemiology and impact of injection drug use and selected comorbidities specifically in pregnant women. It reviews the epidemiology of HIV, viral hepatitis, STIs, and endocarditis and discusses effective medication and behavioral management strategies during pregnancy. Infection prevention and harm reduction approaches are identified as keys to preventing further disease progression.

Activity Details
Start Date: May 25, 2018
End Date: May 25, 2020
Presenter
  • Kinna Thakarar, DO, MPH
    Assistant Professor of Medicine
    Maine Medical Center/Tufts University School of Medicine InterMed Infectious Disease
Registration

There is no fee for this activity, but to receive credit you must register online and complete the online evaluation (you must register to access).

Learning Outcome(s)

Participants will be able to discuss the overall management of pregnant women who have co-morbidities that are often associated with people who inject drugs (PWID), including a clinical checklist for key health issues among PWID, and the discussion of harm reduction/infection prevention strategies.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the activity evaluation. (you must register to access).
Speaker Disclosure

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Improving Care for An Infectious Disease Perspective: Opioid Use Disorder and Commonly Co-Occurring Conditions in Pregnant Women have reported NO financial interest or relationship* which could be perceived as a real or apparent conflict of interest. There were no individuals in a position to control the content that refused to disclose.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:
Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org

For more information on this topic, please go to: https://www.oplc.nh.gov/medicine/opioid-prescribing.htm


Type:     Internet Activity (Enduring Material)
22 Registered Users

0